China SXT Pharmaceuticals, Inc.
NASDAQ: SXTC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Feng Zhou
- Employees
- 75
- Headquarters
- Taizhou, China
- IPO year
- 2019
- Market cap
- $2.0M
- Website
- http://www.sxtchina.com
Loading SXTC…
Loading profile data…Frequently asked questions about SXTC
What does China SXT Pharmaceuticals, Inc. (SXTC) do?
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXu...
Where does SXTC trade?
China SXT Pharmaceuticals, Inc. (SXTC) trades on the NASDAQ.
What sector is SXTC in?
China SXT Pharmaceuticals, Inc. (SXTC) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of China SXT Pharmaceuticals, Inc.?
Feng Zhou is the chief executive officer of China SXT Pharmaceuticals, Inc. (SXTC).
Where is China SXT Pharmaceuticals, Inc. headquartered?
China SXT Pharmaceuticals, Inc. is headquartered in China.
Does SXTC pay a dividend?
China SXT Pharmaceuticals, Inc. (SXTC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SXTC go public?
China SXT Pharmaceuticals, Inc. (SXTC) completed its initial public offering in 2019.